Lifeward Seeks Shareholder Approval for Up to 73% Dilution from Convertible Notes and Warrants
LFWD sits 69% above its 52-week low of $4.14 on light trading volume (0.1× avg).
Summary
Lifeward's definitive proxy sets an October 30 vote on removing the Nasdaq Exchange Cap, which would allow conversion of $5.58M in convertible notes and warrants into up to 2,066,662 shares — approximately 73% of current shares outstanding. The filing also discloses interim CEO compensation and a shift to equity-only director pay to conserve cash.
Key Events · Corporate Governance and Compliance · LFWD
-
Shareholder Vote on 73% Dilution
Proposal 5 asks shareholders to approve issuance of ordinary shares upon conversion of $5.58M in senior secured convertible notes and warrants, exceeding the Nasdaq Exchange Cap. At the $5.40 conversion price, up to 2,066,662 shares would be issued — approximately 73% of the 2,832,016 shares outstanding as of September 23, 2026.
-
Dilution Scenarios Quantified
Full conversion of Securities Purchase Agreement securities alone would result in ~4.9M shares outstanding and ~42.2% dilution to existing holders. Full conversion of both SPA and Prior SPA securities would result in ~10.9M shares outstanding and ~19.0% dilution on the expanded base.
-
Interim CEO Compensation Disclosed
Josh Hexter, appointed interim CEO effective September 1, 2026, receives NIS 100,000 monthly base salary (NIS 1.2M annualized), plus discretionary bonus and potential equity grants. He continues to serve as COO of Oramed, the controlling shareholder, in a reduced capacity.
-
Director Pay Shifted to Equity-Only
Proposal 3 proposes eliminating all cash compensation for non-employee directors, replacing it with annual RSUs valued at $72,570 ($145,140 for the Chairperson) to conserve cash reserves.
Analysis · LFWD · Industrial Applications And Services
Lifeward's definitive proxy sets an October 30, 2026 shareholder vote on Proposal 5, which would remove the Nasdaq Exchange Cap and allow conversion of $5.58M in senior secured convertible notes and accompanying warrants into up to 2,066,662 ordinary shares — approximately 73% of the current 2.83M shares outstanding. The filing quantifies two dilution scenarios: full conversion of the July 2026 Securities Purchase Agreement securities alone would dilute existing holders by ~42.2%, while full conversion of both the SPA and the prior January 2026 Prior SPA securities would dilute by ~19.0% (on a larger share base of ~10.9M shares). This vote is critical because the company has a going-concern warning and cash runway concerns, and the conversion price of $5.40 is below the $7.03 five-day average price at signing, triggering Nasdaq Rule 5635(d) shareholder approval requirements. The proxy also reveals interim CEO Josh Hexter's compensation (NIS 100,000/month) and a proposal to shift all director compensation to equity to conserve cash — both signs of financial strain.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1052 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LFWD was trading at $6.99 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $19.8M. The 52-week trading range was $4.14 to $10.56. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.